Jiangsu (SH:688426) Xin Lang Cai Jing·2025-11-28 06:05Group 1 - The core viewpoint of the news is that Jiangsu Kangwei Century Biotechnology Co., Ltd. has seen a stock price increase of 5.13%, reaching 27.85 CNY per share, with a total market capitalization of 3.133 billion CNY [1] - The company was established on September 3, 2010, and went public on October 25, 2022, focusing on the research, production, and sales of molecular detection products, with 89.14% of its revenue coming from product sales [1] - The trading volume for the stock was 39.9693 million CNY, with a turnover rate of 3.88% [1] Group 2 - Among the top ten circulating shareholders, the fund under Yuanxin Yongfeng has increased its holdings in Kangwei Century by 277,200 shares, now holding a total of 950,000 shares, which represents 2.5% of the circulating shares [2] - The Yuanxin Yongfeng Medical Health A fund has achieved a year-to-date return of 35.33%, ranking 1785 out of 8127 in its category [2] - The fund has a total scale of 387 million CNY and has generated a floating profit of approximately 1.292 million CNY from its recent investment [2]